This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Usv Private Limited. Active years: 2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010
Title: Laxmi Srinivas Rao: Innovator in Recombinant Polypeptide Production
Introduction
Laxmi Srinivas Rao is a notable inventor based in Mumbai, India. He has made significant contributions to the field of biotechnology, particularly in the production of recombinant polypeptides. His innovative approach has the potential to enhance the efficiency of polypeptide production, which is crucial for various medical applications.
Latest Patents
Laxmi Srinivas Rao holds a patent for a chimeric human growth hormone derived from the placenta and pituitary isoform. This invention outlines processes for obtaining said chimera, which can increase the production of recombinant polypeptides. By combining pieces of several different isoforms of a given gene, he has developed a chimeric isoform that can boost polypeptide production by over 25%. Additionally, inserting multiple copies of the coding region in tandem into a transformation vector has shown to increase production by 107%.
Career Highlights
Laxmi Srinivas Rao is currently associated with USV Private Limited, where he continues to work on innovative solutions in biotechnology. His research and development efforts have positioned him as a key player in the industry, contributing to advancements in medical science.
Collaborations
Some of his notable coworkers include Dipanwita Maiti and Shrikant Misiira, who collaborate with him on various projects within the company. Their combined expertise enhances the research capabilities of USV Private Limited.
Conclusion
Laxmi Srinivas Rao's contributions to biotechnology, particularly through his patented innovations, demonstrate his commitment to advancing medical science. His work has the potential to significantly impact the production of recombinant polypeptides, paving the way for future developments in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
